OriGene Technologies is a research tool company that provides a commercial collection of full-length human cDNAs.
OriGene Technologies was founded as a research tool company focused on the creation of the largest commercial collection of full-length human cDNAs. It strives to fulfill its mission of supplying everything a researcher needs for gene-based research. Through licensing and selling research materials including genes, proteins, and research tools, it enables critical biological research.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 24, 2010 | Series B | $16M | 2 | Zero2IPO Capital SBI & TH Venture Capital Enterprise | — | Detail |
Sep 23, 2004 | Grant | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Zero2IPO Capital | Yes | Series B |
SBI & TH Venture Capital Enterprise | Yes | Series B |
National Institutes of Health | — | Grant |